| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |